Lord & Richards Wealth Management LLC Invests $515,000 in Chemed Co. (NYSE:CHE)

Lord & Richards Wealth Management LLC acquired a new position in Chemed Co. (NYSE:CHE - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 972 shares of the company's stock, valued at approximately $515,000.

A number of other hedge funds have also recently made changes to their positions in the stock. HighTower Advisors LLC boosted its stake in shares of Chemed by 78.0% in the third quarter. HighTower Advisors LLC now owns 3,730 shares of the company's stock valued at $2,246,000 after purchasing an additional 1,634 shares during the period. XTX Topco Ltd lifted its holdings in Chemed by 111.5% during the 3rd quarter. XTX Topco Ltd now owns 2,843 shares of the company's stock worth $1,709,000 after buying an additional 1,499 shares in the last quarter. Geode Capital Management LLC boosted its position in Chemed by 4.9% in the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock valued at $201,820,000 after buying an additional 15,791 shares during the period. Signal Advisors Wealth LLC grew its stake in shares of Chemed by 60.7% in the fourth quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company's stock worth $2,647,000 after acquiring an additional 1,886 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Chemed by 8.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 122,788 shares of the company's stock worth $73,792,000 after acquiring an additional 9,178 shares during the period. Hedge funds and other institutional investors own 95.85% of the company's stock.

Analyst Ratings Changes

CHE has been the subject of a number of recent research reports. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th. Royal Bank of Canada reduced their price target on Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 5th.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the sale, the chief executive officer now directly owns 101,735 shares of the company's stock, valued at approximately $58,270,755.95. The trade was a 1.93 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Brian C. Judkins purchased 145 shares of the company's stock in a transaction that occurred on Monday, December 30th. The shares were purchased at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares in the company, valued at $871,721. The trade was a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 3.32% of the company's stock.

Chemed Stock Performance

NYSE CHE traded up $6.23 during trading on Wednesday, reaching $556.57. 97,972 shares of the company's stock were exchanged, compared to its average volume of 88,121. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $654.62. The stock has a market cap of $8.38 billion, a P/E ratio of 28.12, a price-to-earnings-growth ratio of 2.16 and a beta of 0.48. The company has a 50 day moving average price of $542.70 and a two-hundred day moving average price of $564.06.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be issued a dividend of $0.50 per share. The ex-dividend date is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. Chemed's payout ratio is currently 10.11%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.